Rick Tuzi is a
consultant in the Litigation and Dispute Resolution Group at Goodmans. His practice focuses on
intellectual property rights litigation with a particular emphasis on
pharmaceutical patent litigation, including proceedings under the Patented Medicines (Notice of Compliance)
Regulations.
He has worked on
intellectual property cases before the Federal Court and the Trade-marks
Opposition Board. His efforts in these matters have been directed to
representing generic pharmaceutical companies and have led to several patents
being deemed invalid by the Federal Court of Canada.
As a former synthetic
organic chemist and a current registered trade-mark agent, Rick brings relevant
industry experience and perspective to his clients.
